SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-018924
Filing Date
2023-05-24
Accepted
2023-05-24 16:26:14
Documents
65
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1422175
2 ex10-17.htm EX-10.17 3103
3 ex31-1.htm EX-31.1 18851
4 ex31-2.htm EX-31.2 18377
5 ex32-1.htm EX-32.1 7797
6 ex32-2.htm EX-32.2 7909
7 ex10-17_001.jpg GRAPHIC 493359
8 ex10-17_002.jpg GRAPHIC 447697
9 ex10-17_003.jpg GRAPHIC 34484
10 ex10-17_004.jpg GRAPHIC 364674
  Complete submission text file 0001493152-23-018924.txt   8882348

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE aeha-20230331.xsd EX-101.SCH 66192
12 XBRL CALCULATION FILE aeha-20230331_cal.xml EX-101.CAL 44659
13 XBRL DEFINITION FILE aeha-20230331_def.xml EX-101.DEF 278971
14 XBRL LABEL FILE aeha-20230331_lab.xml EX-101.LAB 424502
15 XBRL PRESENTATION FILE aeha-20230331_pre.xml EX-101.PRE 325667
59 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1030033
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 23954481
SIC: 2834 Pharmaceutical Preparations